Concordia International Corp. Provides Update On Its Recently Completed Recapitalization Transaction

MISSISSAUGA, ON, Sept. 11, 2018 /CNW/ – Concordia International Corp. (“Concordia” or the “Company”) (TSX: CXR), an international specialty pharmaceutical company…

You must be a paid subscriber to view this content. To become a new paid subscriber, please go to the REGISTER TAB and choose one of the subscription plans.

error: Content is protected !!
en_USEnglish
en_USEnglish